Cancer Genetics: It doesn't always take two

p807 | doi:10.1038/nrc932

Drug Resistance: Damage limitation

p808 | doi:10.1038/nrc931

Angiogenesis: Multi-tasking

p808 | doi:10.1038/nrc937

Tumorigenesis: Converging paths

p809 | doi:10.1038/nrc940

Tumorigenesis: Clockwork

p810 | doi:10.1038/nrc933

Telomerase: ALTernative pathways?

p810 | doi:10.1038/nrc935

Cell cycle: Divide and rule

p811 | doi:10.1038/nrc934

Oncogenesis: MYC reduces stress

p812 | doi:10.1038/nrc936

Tumour Immunology: Disarming defences

p813 | doi:10.1038/nrc938

Breast Cancer: Filling the hole

p813 | doi:10.1038/nrc939

Vascular and haematopoietic stem cells: novel targets for anti-angiogenesis therapy?

Shahin Rafii, David Lyden, Robert Benezra, Koichi Hattori & Beate Heissig

p826 | doi:10.1038/nrc925

• Abstract
• Full Text
• PDF (618 KB)

Centrosome aberrations: cause or consequence of cancer progression?

Erich A. Nigg

p815 | doi:10.1038/nrc924

• Abstract
• Full Text
• PDF (1,936 KB)

The pathogenesis of pituitary tumours

Sylvia L. Asa & Shereen Ezzat

p836 | doi:10.1038/nrc926

• Abstract
• Full Text
• PDF (1,028 KB)

New aspects of natural-killer-cell surveillance and therapy of cancer

Mark J. Smyth, Yoshihiro Hayakawa, Kazuyoshi Takeda & Hideo Yagita

p850 | doi:10.1038/nrc928

• Abstract
• Full Text
• PDF (1,070 KB)

Cachexia in cancer patients

Michael J. Tisdale

p862 | doi:10.1038/nrc927

• Abstract
• Full Text
• PDF (3,144 KB)